PCS Technology (517119)

Score breakdown: P/E: 1/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Book value of ₹21.13 and P/B of 1.28: the purchase price is only 28% above stated book, giving a concrete asset reference point.
• Piotroski F-Score of 6/9 indicates moderate overall fundamental health, with no obvious red flag in the composite score.
• Trailing earnings grew 35.29%, and PEG is 0.66 if one trusts the quality and durability of that profit growth.
• 52-week range shows liquidity and investor attention: ₹16.70 to ₹30.61, with the current price near the upper end.

Concerns

• Latest quarter has ₹0 Cr sales and ₹0 Cr net profit, making the current operating status unverifiable.
• Sales growth is -9.09%, so the company is shrinking at the top line while the P/E of 23.44 prices in future expansion.
• ROE 3.73% and ROCE 4.85% are far below any acceptable return on equity or capital; value creation is minimal.
• Dividend yield is 0%, promoter holding is N/A, and debt data is not available; transparency and shareholder returns are both weak.

AI Analysis

At ₹26.95, with a market cap of ₹56 Cr, PCS Technology does not pass the first test I apply: what is the durable competitive advantage? This is an IT enabled services business with no evident moat, sales shrinking by 9.09%, and a latest quarter that shows ₹0 Cr sales and ₹0 Cr net profit. That is not an operating company in the normal sense; it is a shell of activity. The weak economics are confirmed by returns on capital. ROE is only 3.73% and ROCE 4.85%. As Graham would say, a business earning less than what I can get from low-risk instruments offers no equity premium. The market price of ₹26.95 gives a P/E of 23.44. For a shrinking revenue base, that multiple demands flawless execution and growth. The trailing profit growth of 35.29% looks tempting, and the PEG ratio of 0.66 makes it look cheap. But when sales are falling by 9%, profit growth from cost-cutting or one-off items is not compounding. I want growing revenue to support growing earnings. Book value is ₹21.13, so at ₹26.95 I am paying a 28% premium over book for a business with a sub-5% return on equity. That is no margin of safety. The Piotroski F-Score of 6/9 suggests moderate financial health, but it does not compensate for missing revenue. There is no dividend yield, promoter holding is not available, and the latest quarterly numbers are blank. The 52-week range tells me the stock has moved from ₹16.70 to ₹30.61 and is now ₹26.95, so Mr. Market is enthusiastic. I cannot share that enthusiasm. This is at best a slow grower with an uncertain future. I would wait for evidence that the business has a real revenue engine and management that earns more than the cost of capital. Until then, I pass.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer